Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Amortization of Deferred Charges (2016 - 2026)

Icon's (ICLR) quarterly Amortization of Deferred Charges came in at $1.5 million in Q2 2026, up 2.55% year-over-year from $1.5 million in Q2 2025, and up 0.66% quarter-over-quarter from $1.5 million in Q1 2026.

Analysis

Icon (ICLR) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends

Icon (ICLR) has reported Amortization of Deferred Charges for 11 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 2.55% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $203.8 million, a 9.44% decrease from a year earlier, with the FY2025 full-year figure at $203.7 million, down 16.05% from the prior year.
  • Amortization of Deferred Charges was $1.5 million for Q2 2026 at Icon, up from $1.5 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $220.6 million in Q4 2024 and troughed at $1.5 million in Q3 2024.
  • A 5-year average of $26.9 million and a median of $3.9 million in 2023 frame the typical range for Amortization of Deferred Charges.
  • Across the five-year window, Amortization of Deferred Charges surged 5530.58% in 2024 and tumbled 91.07% in 2025, its largest moves.
  • Over 5 years, Amortization of Deferred Charges stood at $4.2 million in 2022, then retreated by 6.85% to $3.9 million in 2023, then surged by 5530.58% to $220.6 million in 2024, then fell by 9.68% to $199.2 million in 2025, then slumped by 99.23% to $1.5 million in 2026.
  • The last three Amortization of Deferred Charges figures came in at $1.5 million (Q2 2026), $1.5 million (Q1 2026), and $199.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.53 Mn
Mar 31, 2026 1.52 Mn
Dec 31, 2025 199.20 Mn
Sep 30, 2025 1.50 Mn
Jun 30, 2025 1.49 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 220.55 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 16.70 Mn
Mar 31, 2024 3.91 Mn
Dec 31, 2023 3.92 Mn
Sep 30, 2023 4.59 Mn
Jun 30, 2023 3.40 Mn
Mar 31, 2023 4.50 Mn
Dec 31, 2022 4.21 Mn
Sep 30, 2022 4.36 Mn
Jun 30, 2022 3.41 Mn
Mar 31, 2022 5.78 Mn
Dec 31, 2021 8.44 Mn
Sep 30, 2021 2.86 Mn